Status:
ENROLLING_BY_INVITATION
Centralized Lung Cancer Screening Engagement in At-Risk Populations
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Lung Cancer Screening
Eligibility:
All Genders
50-80 years
Phase:
NA
Brief Summary
This study will assess the impact of centralized outreach on lung cancer screening completion among individuals served by Federally Qualified Health Centers.
Detailed Description
This will be a two-arm, parallel, pragmatic randomized controlled trial (RCT) to evaluate the effectiveness of a centralized patient outreach strategy in increasing lung cancer screening (LCS) complet...
Eligibility Criteria
Inclusion
- Adults aged 50 to 80 years
- Current or past smokers
- Individuals without a recorded LDCT scan within the past year
- Individuals without a prior lung cancer diagnosis
- Active patients of Ryan Health
- Individuals with a mailing address in the New York City area and a phone number on file
Exclusion
- Individuals aged less than 50 or above 80 years
- Individuals without smoking history
- Individuals with a recorded LDCT scan within the past year
- Individuals with a prior lung cancer diagnosis
- Individuals without a mailing address in the New York City area or a phone number on file
- Individuals served by one of Ryan Health clinics where the centralized patient outreach was developed
Key Trial Info
Start Date :
October 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT07216144
Start Date
October 15 2025
End Date
August 1 2027
Last Update
December 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medicine
New York, New York, United States, 10065